Wu Xi App Tec Co., Ltd. has filed its 13F form on November 08, 2024 for Q3 2024 where it was disclosed a total value porftolio of $19 Billion distributed in 2 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Lyell Immunopharma, Inc. with a value of $10.2B and Adagene Inc. with a value of $8.84B.

Examining the 13F form we can see an decrease of $4.29B in the current position value, from $23.3B to 19B.

Wu Xi App Tec Co., Ltd. is based out at Shanghai, F4

Below you can find more details about Wu Xi App Tec Co., Ltd. portfolio as well as his latest detailed transactions.

Portfolio value $19 Billion
Healthcare: $19 Billion

Stock Holdings Table Market Cap. of $50 Millions to $300 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 2
  • Current Value $19 Billion
  • Prior Value $23.3 Billion
  • Filing
  • Period Q3 2024
  • Filing Date November 08, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Wu Xi App Tec Co., Ltd. Portfolio

Follow Wu Xi App Tec Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wu Xi App Tec Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Wu Xi App Tec Co., Ltd. with notifications on news.